Drugs
Former FDA Officials Highlight Evidentiary Challenges for Real-World Data
Former FDA officials and a regulatory evidence expert say real-world evidence could play an increasingly important role in cancer drug development, particularly when randomized clinical trials are impractical, but sponsors must address significant methodological challenges before relying on such data to support regulatory decisions. In an 11/16 FDAWatch